Biocept Inc logo

BIOC - Biocept Inc News Story

$4.68 0.2  4.7%

Last Trade - 11/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.4m
Enterprise Value £34.0m
Revenue £19.4m
Position in Universe 5517th / 6853

BUZZ-Biocept jumps on expansion to urology market, Maxim starts with "buy"

Tue 26th March, 2019 2:10pm
** Shares of medical testing co Biocept Inc  BIOC.O  surged
more than 24 pct early Tues after announcing it would broaden
commercial focus of its target selector biopsy platform
    ** Maxim initiates coverage at "buy," sets $3 PT
    ** Stock last up 16.7 pct at $1.20, among top percentage
gainers on the Nasdaq  .IXIC 
    ** Early Tues BIOC said it would commercialize its pathology
partnership platform EmpowerTC to include urology and
uropathology practices  urn:newsml:reuters.com:*:nPnbvz1msa
    ** Maxim analyst Jason McCarthy views BIOC as undervalued in
oncology testing space, calls its liquid biopsy platform
"potentially best-in-class"
    ** On Feb 7, BIOC announced agreement with privately-held
Agiomix FZ-LLC for validation of liquid biopsy kits in testing
for detection of tumor biomarkers   urn:newsml:reuters.com:*:nPnbL3VVSa   
    ** On Mar 14, the co announced expansion of its pathology
partnership with addition of several key services  urn:newsml:reuters.com:*:nPnbxpq7Xa;
stock jumped nearly 32 pct the next day
    ** Stock has fluctuated widely so far this year; on Jan 17
stock closed up >252 pct YTD
    ** With today's gain, however, BIOC shares have gained ~40
pct so far in 2019

 (Reporting by Stephen Culp)
 ((stephen.culp@thomsonreuters.com; 646-223-6076;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.